Ratings Sharecare, Inc.

Equities

SHCR

US81948W1045

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
0.8558 ^USD	+9.12%		+10.88%	-20.76%

May. 09	Transcript : Sharecare, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09	Earnings Flash (SHCR) SHARECARE Reports Q1 Revenue $90.9M, vs. Street Est of $101.5M	MT

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company's share price in relation to its net book value makes it look relatively cheap.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
SHARECARE, INC.	-20.76%	310M	-
ORACLE CORPORATION	+17.16%	339B	B-
SAP SE	+26.91%	223B	B+
SERVICENOW, INC.	+8.29%	157B	B
CONSTELLATION SOFTWARE INC.	+12.47%	57.55B	D+
FAIR ISAAC CORPORATION	+21.25%	34.88B	C+
HUBSPOT, INC.	+5.99%	31.36B	B+
MICROSTRATEGY INCORPORATED	+150.86%	28.1B	D+
WISETECH GLOBAL LIMITED	+30.09%	21.68B	B-
TOAST, INC.	+47.81%	14.98B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes